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An ecological momentary intervention incorporating personalised feedback to improve 
symptoms and social functioning in schizophrenia spectrum disorders 
 
Authors: 




This study aimed to examine the feasibility and effectiveness of an interactive smartphone 
application with experience sampling method (ESM) derived personalised feedback to 
improve daily-life social functioning and symptoms in schizophrenia spectrum disorders (SZ). 
Two groups of outpatients with a SZ diagnosis were included, one receiving ESM-derived 
personalised feedback (n = 27) and one without feedback (n = 23), using an interactive 
smartphone application for three weeks. Main outcomes were (momentary) symptoms and 
social functioning. Additionally, feasibility and user-friendliness of the application were 
assessed. Response rate was 64% for the ESM questionnaires. In the feedback group, 49% of 
the participants indicated that they acted on at least one personalised feedback prompt per 
day. Momentary psychotic symptoms significantly decreased over time only in the feedback 
group. Momentary loneliness and questionnaire-assessed psychotic symptoms decreased 
over time, irrespective of feedback. Participants evaluated the SMARTapp as user-friendly and 
understandable. Momentary personalised feedback may impact momentary psychosis in daily 
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life. Feelings of loneliness and questionnaire-based measured psychotic symptoms may be 
more responsive to non-specific effects of daily-life self-monitoring, not requiring specific 
feedback. Ecological momentary interventions offer opportunities for accessible and effective 
interventions in SZ. 
 
Keywords: psychoses; experience sampling method; mobile health; treatment; 




Schizophrenia spectrum disorders (SZ) are characterised by social and community dysfunction 
(Couture et al., 2006; Garrido et al., 2013). In addition to positive and negative symptoms like 
hallucinations, delusions and anhedonia, difficulty in navigating the social world has a 
substantial impact on daily-life functioning (Couture et al., 2006; Fett et al., 2011; Velthorst et 
al., 2016). This is reflected in key characteristics of the disorder, e.g. social withdrawal and 
poor social interactions (Billeke and Aboitiz, 2013; Penn et al., 1996), as well as difficulties in 
maintaining relationships with family and friends (Burns and Patrick, 2007; Pinkham and Penn, 
2006). Functional and social impairments remain a challenge to treat (Robinson et al., 2004; 
Wykes et al., 2008). If social functions are targeted in interventions, effects often do not 
transfer to daily life (Couture et al., 2006; Pos et al., 2019; Roberts and Velligan, 2012), which 
may be related to the low (social) motivation associated with a diagnosis in the schizophrenia 
spectrum (Medalia and Saperstein, 2011). Supplementing treatment with support in real life 
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may lead to greater functional improvement (Berry and Haddock, 2008; Bradshaw et al., 
2007). This is, for instance, implemented by the Social Cognition and Interaction Training 
(SCIT) (Penn et al., 2007), which facilitates practice outside the therapy sessions. The SCIT 
shows promising results on social functioning. An easy and useful, and less resource intensive, 
way to improve social functioning in the context of daily life for patients with a SZ diagnosis 
may lie in further integration with mobile health applications. 
 Mobile phone ownership and the willingness to engage with mobile health (mhealth) 
is growing in populations diagnosed with a mental health disorder and up to 81% of patients 
diagnosed with schizophrenia own a smartphone (Firth et al., 2015; Lim and Penn, 2018; 
Visser et al., 2018). One of the most widely-used and validated methods to monitor 
experiences and behaviour in the flow of daily life is the Experience Sampling Method (ESM), 
also called Ecological Momentary Assessment (Delespaul, 1995; Granholm et al., 2011; 
Granholm et al., 2007; Myin-Germeys et al., 2009). In ESM, participants answer a set of 
questions several times a day at random intervals, which allows for real-time monitoring of 
behaviour, mood, symptoms and context. Incorporating ESM in mhealth interventions 
provides promising opportunities in promoting health behaviour in the general population 
(Heron and Smyth, 2010) and more recently, in psychiatric disorders (Granholm et al., 2007; 
Hartmann et al., 2015; Kramer et al., 2014; Myin-Germeys et al., 2016; Visser et al., 2018). For 
example, prodromal symptoms of relapse in schizophrenia were identified successfully by 
monitoring fluctuations in momentary symptoms, causing a reduction of the number 
hospitalizations by 60% (Španiel et al., 2008). Another mobile intervention study offered 
prescheduled and tailored interventions targeting voices, mood, sleep, social functioning and 
medication use. After using the application for one month patients showed a decrease in 
psychotic symptoms, depression and general psychopathology (Ben-Zeev et al., 2014). Others 
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showed that sending automated pre-programmed personalised text messages in response to 
ESM entries increased social interactions (Granholm et al., 2011). In addition, motivational 
aspects in daily life can be targeted through a mobile intervention in an early psychosis 
sample; improving self-reported symptoms of depression, defeatist beliefs, self-efficacy, and 
showed a marginal increase in motivation and pleasure (Schlosser et al., 2018). While these 
studies yielded initial evidence of beneficial effects, they did not include an ESM control 
group. Research shows that patients often experience a therapeutic effect in monitoring their 
experiences and behaviour, whether they use mobile devices or a paper and pencil method. 
Monitor symptoms in daily life during cognitive behavioural therapy improves the outcome of 
the treatment (Firth and Torous, 2015; Os et al., 2013; Torous and Firth, 2016). One study 
investigated a single-session intervention augmented by automated prompts on a mobile 
device in serious mental illness (schizophrenia and bipolar disorder). Three groups were 
included: with and without personalised cognitive behavioural therapy (CBT) prompts and a 
treatment as usual (TAU) group. The intervention resulted in modest, yet sustained 
improvement in general psychopathology, measured by questionnaires, in both CBT groups; 
with and without automated prompts. Incorporating personalised elements of CBT through 
automated prompts had an additional positive impact on community functioning and 
defeatist attitudes (Depp et al., 2018). 
 The current randomized controlled study included an experimental group that 
received personalised feedback prompts in response to their answers on the ESM 
questionnaires and an ESM control group that did not receive such feedback to disentangle 
symptom monitoring effects and personalised feedback effects. We were interested in 
whether using an interactive smartphone application is feasible in a SZ sample and whether 
providing personalised ESM-derived feedback can ameliorate symptoms and improve social 
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functioning. We tested the corresponding hypotheses: (1) the application would be usable 
and understandable, and (2) the interactive feedback group compared to the no-feedback 
group would show larger improvements over time in momentary symptoms and social 
functioning, as measured by ESM, and symptoms and social functioning, as measured pre- 




Sixty-four individuals with a SZ diagnosis were included. Participants were recruited through: 
1) research collaborators; 2) assertive community treatment teams, i.e. GGZ inGeest, GGZ 
Delfland, Mentrum, Arkin, Altrecht, Dijk en Duin, and Yulius; 3) hospitals, i.e. Amsterdam 
Medical Centre, University Medical Centre Utrecht; and 4) with the help of patient- and 
relative associations, i.e. Anoiksis, Ypsilon, Phrenos, and PsychoseNet. Inclusion criteria for all 
participants were: a) a SZ diagnosis according to the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-V; (American Psychiatric Association, 2013)); b) age between 18-60 
years; c) an IQ of above 70; d) able to read and understand Dutch; and (e) the ability and 
willingness to sign informed consent. This study was approved by the medical research ethics 
committee of the Medical Centre of the VU University Amsterdam [NL56511.068.16]. 
 Of the 64 participants enrolled, 14 dropped out of the study for a variety of reasons: 
one participant was excluded because of the wrong diagnosis, and for four participants data 
was lost due to technical errors during the automated data transfer. There were 9 non-
completers, three of whom withdrew from the study due to various (personal) reasons, and 
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six of whom completed fewer than 30% of the ESM questionnaires. Some additional 
information on the subjective experiences of these latter six participants are summarized in 
supplement C.  There were no significant differences between completers and non-
completers on any of the investigated demographic or clinical characteristics (see supplement 
B - Table 1). Therefore, the final data analysis of this study included 50 participants. 
 
2.2 Measures 
The Positive and Negative Syndrome Scale (PANSS; Kay et al. (1987)) was used to assess 
positive and negative symptoms in the two weeks before testing to get a baseline measure of 
symptoms. Participants’ subclinical self-reported positive and negative psychotic symptoms 
one week prior to testing were assessed with the Community Assessment of Psychic 
Experiences (CAPE; (Konings et al., 2006); Stefanis et al. (2002)). This self-report measure is 
sensitive to pick up on subtle changes during the three-week intervention period. The Social 
Functioning Scale (SFS; Birchwood et al. (1990)) was included to assess social functioning in 
the domains social withdrawal, interpersonal functioning, recreation activities and pro-social 
activities. Two subtests of the Wechsler Adult Intelligence Scale (WAIS-III; Wechsler et al. 
(1997)) were used as an indicator of general cognitive ability: the vocabulary subtest, a verbal 
comprehension task, and the letter- and number span subtest, a working memory task. 
 
2.3 The SMARTapp 
The SMARTapp (Schizophrenia Mobile Assessment and Real Time feedback application) was 
made using custom questionnaires which were built on the PsyMate™ platform 
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(www.psymate.eu), which is a platform including a smartphone app, a cloud-based data 
storage and a reporting module, that allows customized collection of ESM data (thoughts, 
feelings, and behaviour) in everyday life. Research has shown that patients found the 
PsyMateTM application user-friendly and that it is easily accessible even for people who are 
not acquainted with smartphones and its applications (Myin-Germeys et al., 2011). 
Participants were randomly assigned to either of two groups: (1) one where the SMARTapp 
provided feedback according to the participants’ daily ESM entries, or (2) one where the 
SMARTapp included only ESM questionnaires without personalised feedback. 
 All participants completed up to six short ESM questionnaires daily when prompted by 
a beep, for a duration of three weeks. In the morning, all participants received a medication 
and morning hygiene reminder. The ESM-beeps occurred semi-randomly between 9:00 and 
22:00; within time blocks of 130 minutes to ensure accurate representation of the flow of 
their daily lives. Symptoms, social activities and mood were assessed. Furthermore, 
participants were asked to fill in one additional evening questionnaire before they went to 
bed (available from 20:00 until 04:00). This questionnaire asked general questions about their 
day (e.g., “I have been alone for most part of the day”), and whether using the application 
had influenced their day. Questions were answered on a 7-point Likert scale, by fixed answer 
choices or with a binary yes/no answer. Items that were used to measure social functioning 
included questions about social engagement, feelings of exclusion and loneliness (see 
supplement D - Table 1 for ESM questions). Symptoms were assessed in the domain of 
psychotic experiences and positive and negative affect (e.g. cheerful, relaxed, irritated, 




2.4 Personalised feedback vs no-feedback group  
The SMARTapp was identical for both groups, except that one group received personalised 
interactive ESM-derived feedback from the application in the form of two tailored prompts a 
day. The prompts provided suggestions for a certain activity or behaviour change, depending 
on the previous ESM answers. The application provided feedback in the following categories: 
a) psychotic symptoms, b) social engagement, c) health behaviour (i.e. sleep, eating), d) 
physical activity, and e) mood and emotion. Feedback-prompts were programmed in such a 
way that even if ESM questions were answered in a similar fashion, participants did not 
receive the same prompt twice in a day. In the evening questionnaire, the feedback group 
was asked whether they acted upon the suggestions or not. 
 
2.5 Procedure 
All participants received written information by mail or e-mail prior to the first visit. They 
were asked to complete a personal-items-checklist regarding their favourite activities, coping 
mechanisms and social contacts, and to bring this list with them to the first (baseline) session. 
Testing took place at the VU University Amsterdam. Participants first gave written informed 
consent and then completed a battery of clinical measures (see Figure 1). Participants who did 
not own a smartphone (14% across completers and non-completers), were provided with one 
(model: LG K120E), and for them additional training was provided on how to use the 
smartphone. The application was personalised for all participants, both with and without 
feedback, according to the personal preferences of the participant. For instance, participants 
filled in enjoyable activities, several social contacts, comforting thoughts and relaxing 
activities. They could access the comforting thoughts and relaxing activities at any time in the 
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application. Other information, i.e. enjoyable activities and social contacts, were used to 
provide personalised feedback (see Supplement A for personal list and coping tips). After this, 
the different elements in the SMARTapp were explained, as well as the meaning of the 
questions and response options and participants completed a practice ESM questionnaire 
together with the researcher. Participants were instructed to carry their phone with them and 
to complete the ESM questions whenever possible. They received written information about 
the study to take home. 
 Participants used the application for a period of 21 days. On day two and day seven 
participants were contacted by phone to check for technical difficulties and whether they had 
any additional questions. A contact number was provided for technical support. All data was 
automatically uploaded to a secure server according to the EU data protection guidelines.  
 After three weeks participants attended the second session during which they 
completed the post-measures (see Figure 1). To make sure that the load of the first session 
was not too much, we assessed the WAIS in the second session. Participants were then asked 
about their experiences with the application to assess feasibility and after this they were 
debriefed about the two conditions and the purpose of the study. After revealing their 
SMARTapp version, participants in the no-feedback group were offered to continue using the 
application with interactive feedback. All participants were given 150 Euro for study 
participation.  
 
2.6 Data analysis 
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Statistical analyses were conducted using STATA 14.1 (StataCorp, 2015). To inspect the 
differences between groups on demographics and clinical characteristics at baseline 
regression analyses and chi-square tests were used. 
 For the ESM questions, a mean per beep was calculated for each participant for 
psychotic symptoms (‘suspicious’, ‘disliked’, ‘harmed’, ‘voices’, ‘apparitions’), positive affect 
(‘cheerful’, ‘relaxed’, ‘content’), and negative affect (‘irritated’, ‘sad’, and ‘ruminating’). These 
were used as dependent variables, as were social functioning outcomes (‘prefer not to be 
alone’, ‘feeling excluded’ and ‘feeling lonely’), the evening question (‘I have been alone for 
the most part of the day’) and questionnaire outcomes (CAPE and SFS). Mixed multilevel 
regression analyses were used to account for repeated observations within subjects 
(minimum of 38 per participant, 30 % of the beeps in 21 days), with group (feedback vs. no-
feedback) and time (all ESM questionnaires over time / baseline - post intervention) and their 
interaction as independent variables. In a similar fashion, logistic multilevel regression 
analyses were run to examine being alone (yes/no) over time. 
 
3. Results 
3.1 Demographics and baseline symptoms 
Participant demographic information and clinical characteristics are shown in Table 1. The 
feedback and the no-feedback group differed in baseline negative symptoms; the feedback 
group had a lower negative PANSS scale score than the no-feedback group. The CAPE and SFS 
baseline scores are displayed in Table 3. The feedback group had a significantly higher score 
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on interpersonal functioning at baseline measured with the SFS (b = -0.71, 95%CI [.16, 1.27], p 
= .01), all other CAPE and SFS baseline scores did not differ between groups (all p ≥ .21). 
 
3.2 SMARTapp use 
The completers replied to 80 beeps (SD = 22.3) over three weeks (64%). The minimal was 40, 
maximum 126 (of 126). Including the six non-completers, who were dropped because of too 
little beeps, an average of 74 beeps (SD = 27.1) were completed (59%). No significant 
differences were found for completion between the feedback and no-feedback group (p = 
.76). The same pattern was found including the six non-completers (p = .81). The completion 
rate for evening questionnaires 18 (SD = 4.1 or 84% (range 2 to 21 = max.). There were no 
significant differences between the feedback and no-feedback group (p = .40). 
At the end of the day, the interactive version of the application asked participants 
whether they acted on the feedback suggestions. Participants reported that on 49% of the 
ESM days they followed at least one of the two suggestions they got from the personalised 
prompts. The percentage of given feedback in each category was: 1) psychotic symptoms 
7.5%, 2) social engagement 17.1%, 3) health behaviour 10.8%, 4) recreational or physical 
activity 43.9%, and 5) mood 20.3%. 
 
3.3 Change in momentary symptoms and social functioning 
Averages of ESM outcomes per week are displayed in Table 2. There was a significant group-
by-time interaction for momentary psychotic symptoms measured by ESM (b = -0.005, 95%CI 
[-.01, -.0006], p = .03). Analysis by group showed that psychotic symptoms significantly 
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decreased in the feedback group (b = -0.003, 95%CI [-.006, .-0005], p = .02), Cohen's d = -0.30 
(week 1 to week 3). This decrease was not found in the no-feedback group (b = 0.002, p = .31).  
No group-by-time interaction or main effects in the model without the interaction were found 
for positive or negative affect (all p ≥ .24). 
 For the preference not to be alone or feeling excluded by others there was no group-
by-time interaction or main effects of group or time in the model without the interaction (all p 
≥ .34), nor was there any effect on being alone measured by the evening questionnaire (all p 
≥ .10). There was no group-by-time interaction and, in the model without the interaction, no 
group effect on loneliness (both p ≥ .48), however, loneliness did decrease significantly over 
time in both groups (b = -.004, 95%CI [-.007, -.0009], p = .01), Cohen's d = -0.11 (week 1 to 
week 3). Multilevel logistic regression analyses showed no significant group-by-time 
interaction, nor any main effects on being alone in the model without the interaction (all p ≥ 
.69). 
 
3.4 Change in questionnaire-based measures of symptoms and social functioning 
We examined the effect of group on questionnaire measures for symptoms and social 
functioning (for pre- and postscores see Table 3). For CAPE positive symptoms there was no 
group-by-time interaction or a main effect of group in the model without the interaction 
(both p ≥ .59), however, there was a main effect of time (b = -2.5, 95%CI [.20, .32], p < .01), 
showing less positive symptoms post-intervention in both groups. For the negative and 
depressive dimension there were no significant interaction or main effects (all p ≥ .08). 
 There was no group-by-time interaction for SFS interpersonal functioning (p = .81), 
however, in the model without the interaction, there was a significant effect of group on the 
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SFS interpersonal functioning subscale (b = .76, 95%CI [.20, .32], p < .01), indicating that the 
feedback group had higher baseline and post-intervention levels of interpersonal functioning, 
which did not change over time (p = .83). The SFS subscales social withdrawal, prosocial 
activities or recreational activities did not show any significant effects (all p ≥ .13). 
 
3.5 Participant evaluation of the application 
Participants rated the SMARTapp as easy to use (94%) and appealing (95%), indicated that 
questions were clear (80%), and generally felt that they could reflect their experiences well 
through the questions provided by the application (68%). Seventy-four percent of the 
participants opened the coping tips, and 54% found them useful (43% neutral, 3% not useful). 
In the no-feedback group, 38% found the application annoying at some point compared to 
73% in the feedback group (significantly different, χ2= 5.06, p = .03), for example, some 
participants indicated that there were too many beeps during the day and that they 
sometimes felt disturbed in their activities by the beep. 
 
4. Discussion 
This ecological momentary intervention study aimed to investigate whether an interactive 
smartphone application providing personalised feedback was feasible in SZ and whether it 
would improve psychotic symptoms and social functioning. One group received personalised 
ESM-derived feedback, while the other group received the ESM questionnaires without any 
personalised feedback, to disentangle the ESM and feedback effects. The findings indicate 
good feasibility, with high compliance to the application that was rated as user-friendly and 
understandable. Receiving personalised feedback was associated with a reduction in 
momentary psychotic symptoms, measured in daily life, in comparison to the no-feedback 
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group. Regardless of whether participants received feedback or not; feelings of loneliness 
decreased and psychotic symptoms as measured by the CAPE questionnaire decreased. 
 
4.1 Effect of the SMARTapp on symptoms and affect 
As hypothesized, momentary psychotic symptoms showed a significant decrease over time in 
the feedback, but not in the no-feedback group, suggesting a beneficial effect of the provided 
prompts. While the no-feedback group showed no changes in momentary psychotic 
symptoms, a positive effect on psychotic symptoms in both groups was found on the CAPE 
questionnaire, showing that psychotic symptoms declined after three weeks. It may be that 
the no-feedback group, in retrospect, subjectively rated positive symptoms as being lower in 
the last 3 weeks, while this was not confirmed by the daily ESM entries, possibly reflecting 
differences between in the moment and retrospective ratings (Moran et al., 2017). The 
difference may be related to the reliance on patients’ long-term memory about their 
experiences or feelings in the previous weeks. Prospective measurements better reflect the 
actual mental states. Accumulated sampled measurements best reflect the mental state 
during the period. Contrary to our hypothesis, no significant group difference was found for 
negative symptoms measured by the CAPE. Both groups showed a decline in negative 
symptoms, although this did not reach significance (p = .075).  
 Momentary positive or negative affect did not change over time and did not differ 
between groups. This may be related to relatively high average of positive affect and a low 
average of negative affect at the beginning of this study (e.g. ceiling and floor effects) 
(Huppert, 2001) or it may be that the application does not impact on affect, which seems to 
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be in line with results from an ecological momentary intervention study in depression 
(Hartmann et al., 2015). 
 
4.2 Effect of the SMARTapp on social functioning 
We found a decrease in loneliness over time in both groups, as indicated by ESM entries. We 
did not find an effect on social engagement (i.e. being alone). This does not support the 
hypothesis that participants in the feedback group would show greater improvement in social 
engagement than the no-feedback group. Decreasing loneliness is important, because 
loneliness ratings among individuals with a schizophrenia spectrum disorder are high (up to 
80%) (Stain et al., 2012) and loneliness is a significant contributor to quality of life and 
subjective well-being (Eglit et al., 2018). The decrease in loneliness may be partly explained 
through use of the application itself, related to the monitoring of experiences or coping tips 
(Firth and Torous, 2015; Os et al., 2013; Torous and Firth, 2016) or by the regular contact with 
the research team. In addition, participants may be more inclined to enrol in a treatment 
study when they are more symptomatic and therefore, these improvements in loneliness, and 
in positive symptoms measured by the CAPE, could possibly reflect a relative turn towards the 
better during the fluctuating course of their illness. During the evaluation of the SMARTapp, 
some participants indicated that ‘it felt like someone was there for them’ and ‘someone 
listened to them’ while using the application. Future research with a waitlist control group will 
be necessary to disentangle these effects. 
 Overall and the distinct domains social functioning, as measured by the SFS, did not 
change over time and did not show a differential effect of feedback vs. no-feedback. Other 
research also failed to find effects of interactive feedback on questionnaire-based 
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assessments of symptoms and functioning (Granholm et al., 2011), but did find an effect on 
daily-life social engagement in a 12-week intervention. It is possible that questionnaire 
measures may not be sensitive enough to detect subtle changes in social functioning and that 
the study period of three weeks was too short to have a significant beneficial effect on social 
interactions. Integrating more sensitive measures, e.g. performance-based measures of social 
competence, might be more successful in detecting changes in functioning (Bowie et al., 
2008) and it may be helpful to include (social) motivational aspects specifically in a mobile 
intervention to increase social engagement (Schlosser et al., 2018). In addition, integrating 
mobile sensing, i.e. acquiring data from the environment through a smartphone, may be 
useful to detect subtle changes in activity levels in an objective way, through geolocations or 
telephone calls in patients’ daily live context (Ben-Zeev et al., 2015; Seppälä et al., 2019). 
Future studies including personalised feedback may benefit from incorporating video’s as 
feedback, since studies show that patients prefer video interventions because they are found 
to be more personal, engaging, and helpful than written interventions (Ben-Zeev et al., 2018). 
 
4.3 Feasibility of the SMARTapp 
The mobile phone ownership of participants in this study was high (86%) and in line with 
previous literature (Firth et al., 2015; Lim and Penn, 2018; Visser et al., 2018). Results on the 
feasibility of the application were generally positive and compliance was high (64% of the ESM 
questionnaires and 84% of the self-initiated evening questionnaires). The completion did not 
change over the three week course (63.5%, 51.3% end 66.7% respectively). Also, patients 
receiving ESM-derived feedback attempted to apply suggestions to their daily lives. 
Participants generally found the application easy to use, appealing and the questions clear 
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and easy to understand. The feedback group indicated more annoyance from the application, 
which may be related to a higher number of beeps in total compared to the no-feedback 
group causing more irritation and disruptions in daily life. Not all participants indicated a 
reason for feeling annoyed; therefore we cannot pinpoint the precise reason. However, some 
participants indicated that they sometimes received feedback that was not relevant at the 
time that they received it. For example, receiving feedback about contacting someone after 
being alone for most part of the day may not be relevant anymore if the participant just 
visited a friend or family member. On the other hand, we speculate that participants’ 
annoyance may increase because they find it hard to find the motivation to call someone or 
to go and be active, even after receiving a feedback suggestion. Future studies should 
elucidate what the optimal number of beeps is to foster continuous engagement with the 
app, but not disturbance. In addition, feedback options may be enriched by advice from the 
patient community, to ensure more relevant and creative suggestions. 
 
4.4 Limitations and future directions 
Some limitations must be considered with respect to the study findings. First, the results 
should be considered as preliminary because of a relatively small study sample, which may 
not provide sufficient power to pick up on interaction effects. Second, the intervention period 
of three weeks was relatively short. Mobile interventions may need a longer period of time to 
be able to promote long-term lifestyle changes rather than in the moment coping strategies 
(Ben-Zeev et al., 2014). However, one of the biggest advantages of working with ESM data is 
that through this collection technique subtle changes can be detected that might not be 
detected by standard questionnaire measures (Delespaul, 1995; Kimhy et al., 2012; Os et al., 
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2013). Third, multiple topics of symptoms, functioning and health-related behaviour were 
included in the feedback prompts. Because of this, prompts were not solely directed to 
symptoms or social behaviour. A stronger focus on feedback targeting social functioning may 
be more effective in improving functional outcome. Last, the study had no waitlist/treatment 
as usual control group; as such we cannot compare the results in the current study to TAU 
and are unable to differentiate between ESM without feedback and TAU influences. 
 
4.5 Conclusion 
This study suggests that mobile applications are feasible and incorporating personalised 
feedback prompts could be beneficial for individuals with a SZ disorder in reducing 
momentary psychotic symptoms. Decreased feelings of loneliness and questionnaire 
measured psychotic symptoms for all participants may be related to positive effects of 
monitoring symptoms and experiences in daily life, study participation or a natural change for 
the better. Smartphone-based modalities with personalised feedback offer opportunities for 
simple and accessible interventions. They also offer a way to empower patients to take an 
active role in their mental health management. For future studies, it would be of particular 
interest to investigate whether the close integration of mobile interventions with 
personalised feedback in existing face-to-face treatments could further improve outcomes. 
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ESM outcomes by week for the no-feedback and feedback group 
 Feedback (n = 27)  No-feedback (n = 23)  
 Week 1 Week 2 Week 3  Week 1 Week 2 Week 3  
 Mean (SD)  Mean (SD)  
ESM outcomes         
Psychotic 
symptoms 
1.48 (0.86) 1.34 (0.66) 1.26 (0.59) ↓* 1.62 (0.79) 1.62 (0.89) 1.72 (0.96)  
Positive affect 5.19 (1.11) 5.21 (1.16) 5.31 (1.18)  4.81 (1.51) 4.96 (1.58) 4.81 (1.60)  
Negative affect 2.01 (1.13) 2.01 (1.20) 1.91 (1.07)  2.28 (1.38) 2.14 (1.38) 2.28 (1.43)  
Loneliness 2.15 (1.48) 2.08 (1.49) 1.91 (1.33) ↓* 2.53 (1.78) 2.26 (1.69) 2.44 (1.74) ↓* 




Prefer not to be 
alone 
2.83 (1.65) 2.98 (1.72) 2.70 (1.74)  3.06  
(1.94) 
3.09 (2.07) 3.26 (2.16)  
Being alone 59.9% 62.4% 62.1%  55.3% 56.4% 55.2%  
Evening 
questionnaire 
        
Alone most of 
the day 
3.16 (1.89) 3.04 (1.85) 2.84 (1.79)  2.93 (1.96) 2.99 (1.89) 2.92 (1.82)  
* significance level p < .05 




Feedback (n = 27) 
Mean (SD) 











CAPE       
positive [range 20-80] 29.3 (9.5) 27.2 (8.8) ↓* 30.9 (9.9) 27.8 (7.0) ↓* 
negative [range 14-56] 27.5 (8.6) 25.3 (8.0)  27.6 (8.8) 26.9 (8.9)  
depressive [range 8-32] 14.9 (4.8) 13.8 (3.8)  15.7 (6.2) 15.2 (5.8)  
SFS       
social withdrawal [max. 15] 9.9 (2.5) 10.1 (2.4)  9.3 (2.9) 9.3 (3.1)  
interpersonal functioning [max. 9] 6.9 (0.9) 6.9 (0.9)  6.2 (1.1) 6.1 (1.9)  
prosocial activities [max. 66] 17.9 (9.4) 17.4 (9.8)  14.5 (9.2) 13.6 (7.6)  
recreational activities [max. 45] 21.0 (5.3) 20.8 (4.9)  20.4 (7.7) 19.3 (7.2)  
* significance level p < .05 








Supplementary material: A - D 
Supplement A: Additional information non-completers due to < 30% of beeps 
Six out of the 9 non-completers were dropped because of too little beeps (< 30%). According 
to the evaluation/debriefing questionnaire five out of the six drop outs were positive about 
the app. They found the app useful, easy to use, clear, fun and interesting. One participant 
said that he found it difficult to comply because the beeps annoyed him. However, he liked 
the relaxation exercises offered in the app. One participant indicated that he preferred more 
and louder beeps. Four non-completers replied that the intervention was stressful due to 
personal reasons (e.g. relationship ended, bird died, going through a divorce and a recurrent 
trauma and jobhunting pressure). One participant in the feedback group indicated that the 













Supplement B - Table 1 






M (SD) / % 
Non-Completer 
N=9 
M (SD) / % 
Statistic p 95% CI 
Age - M (SD) 39.0 (9.7) 43.4 (7.8) b = -.006 .21 [-.02, .004] 
Gender (% male) 32 (64.0) 6 (66.7) χ2= 0.02 .88  
WAIS Vocabulary 45.4 (10.7) 41.7 (13.1) b = .003 .41 [-.005, .01] 
WAIS Letter number span 10.0 (2.5) 8.0 (3.4) b = .03 .06 [.25, .90] 
Living status 
   Alone 
   With partner and or children  
   With family/friends/roommate 











χ2= 2.97 .40  
Working status 
   Employed 
   Unemployed 
   Unstructured activities 











χ2= 6.20 .10  
Diagnoses (%) 
   Schizophrenia 
   Schizoaffective disorder 
   Psychotic disorder 











χ2= 0.77 .86  
Medication (%) 
   Atypical antipsychotics 
   Typical antipsychotics 









χ2= 3.07 .22  
PANSS      
general [range 16-112] 28.4 (7.0) 30.0 (8.6) b = -.004 .54 [-.02, .01] 
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negative [range 7-49] 13.62 (5.2) 14.3 (3.0) b = -.004 .69 [-.02, .02] 
positive [range 7-49] 15.2 (5.4) 15.3 (8.0) b = -.0006 .95 [-.02, .02] 
CAPE      
positive [range 20-80] 30.0 (9.6) 24.4 (5.4) b = 5.56 .1 [-1.07, 
12.18] 
negative [range 14-56] 27.5 (8.6) 23.0 (7.0) b = 4.54 .14 [-1.56, 
10.64] 
depressive [range 8-32] 15.2 (5.5) 12.2 (3.3) b = 3.00 .17 [-.77, 6.77] 
SFS      
social withdrawal [max. 15] 9.6 (2.7) 11.1 (2.2) b = -1.49 .13 [-3.41, .43] 
interpersonal functioning [max. 
9] 
6.6 (1.0) 6.2 (1.5) b = .34 .40 [-.47, 1.14] 
prosocial activities [max. 66] 16.3 (9.4) 18.8 (10.1) b = -2.46 .48 [-9.31, 4.39] 
recreational activities [max. 45] 20.8 (6.4) 21.8 (7.3) b = -1.02 .67 [-5.77, 3.73] 
 
 
Supplement C – Table 2 
Table 1 
Main outcomes: ESM questions 
Category Example answer possibilities 
Social functioning  
Who is with you at this moment? No-one  
 Partner, family or friends 
 Co-workers or acquaintances 
 Strangers 
I would rather be in the company of 
others 
1: Not at all  7: Very much so 
I feel lonely 1: Not at all  7: Very much so 
I feel excluded by others 1: Not at all  7: Very much so 
Psychotic Symptoms  
I feel like others do not like me 1: Not at all  7: Very much so 
I feel like others want to harm me 1: Not at all  7: Very much so 
I am hearing voices  1: Not at all  7: Very much so 
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I am seeing things that others cannot see 1: Not at all  7: Very much so 
How suspicious do you feel right now? 1: Not at all  7: Very much so 
Positive affect  
I feel cheerful 1: Not at all  7: Very much so 
I feel relaxed 1: Not at all  7: Very much so 
I feel content 1: Not at all  7: Very much so 
Negative affect  
I feel irritated 1: Not at all  7: Very much so 
I feel sad 1: Not at all  7: Very much so 
I am ruminating 1: Not at all  7: Very much so 
 
Supplement D: The personal list and coping tips 
To make sure the application was engaging and the feedback more personal, the application 
was personalised together with the research assistant at the end of the baseline session. 
Personalisation of the SMARTapp consisted of entering several aspects in the application: (i) 
activities the participant enjoys doing, (ii) important contacts, (iii) activities the participant 
finds relaxing, and (iv) comforting thoughts. The personal list, thus, consisted of an overview 
of what the participant filled in during the baseline session and could be looked into at any 
time necessary. These personal items were used in the personalised suggestions that the 
feedback group received. 
 The coping tips allowed users to access resources and suggested coping strategies 
from a menu of categories, e.g. physical activity, social activity, relaxation, dealing with 
symptoms, and sleeping. The coping tips were available at any time in both versions of the 
application. Participants were instructed to use the coping tips whenever they felt that they 
needed support. 
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